Gamma knife radiosurgery for medically and surgically refractory prolactinomas: Commentary Article uri icon

Overview

MeSH Major

  • Pituitary Gland
  • Pituitary Neoplasms
  • Prolactinoma
  • Radiosurgery

abstract

  • Clinical remission in 26% of treated patients is a modest result. However, because the GKRS treated tumors were refractory to other therapies and because complication rates were low, GKRS should be part of the armamentarium for treating refractory prolactinomas. Patients with tumors smaller than 3.0 cm3 and who are not receiving dopamine agonist at the time of treatment will likely benefit most.

publication date

  • August 2006

Research

keywords

  • Article

Identity

Digital Object Identifier (DOI)

  • 10.1227/01.NEU.0000223445.22938.BD

Additional Document Info

start page

  • 255

end page

  • 66; discussion 255-66

volume

  • 59

number

  • 2